Mechanisms of amyloid fibril self-assembly and inhibition: Model short peptides as a key research tool

FEBS Journal

Volumn 272, Issue 23, 2005, Pages 5971-5978

  Gazit, Ehud ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Amyloid formation; Molecular recognition; Protein folding; Protein misfolding; Protein protein interactions; Self assembly; Stacking interactions

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; CREUTZFELDT JAKOB DISEASE; DISEASE ASSOCIATION; HUMAN; MEDICAL RESEARCH; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN INTERACTION; SHORT SURVEY;

AMINO ACID SEQUENCE; AMYLOID; AMYLOIDOSIS; ANIMALS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PEPTIDES;

EID: 28244458451     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2005.05022.x     Document Type: Short Survey

References (57)

1. Sunde M & Blake CC (1998) From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. Q Rev Biophys 31, 1-39.
2. Rochet JC & Lansbury PT Jr (2000) Amyloid fibrillogenesis: Themes and variations. Curr Opin Struct Biol 10, 60-68.
3. Serpell LC (2000) Alzheimer's amyloid fibrils: Structure and assembly. Biochim Biophys Acta 1502, 16-30.
4. Dobson CM (2001) Protein folding and its links with human disease. Biochem Soc Symp 68, 1-26.
5. Sacchettini JC & Kelly JW (2002) Therapeutic strategies for human amyloid diseases. Nat Rev Drug Discov 1, 267-275.
6. Guijarro JI, Sunde M, Jones JA, Campbell ID & Dobson CM (1998) Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci USA 95, 4224-4228.
7. Gross M, Wilkins DK, Pitkeathly MC, Chung EW, Higham C, Clark A & Dobson CM (1999) Formation of amyloid fibrils by peptides derived from the bacterial cold shock protein CspB. Protein Sci 8, 1350-1357.
8. Chapman MR, Robinson LS, Pinkner JS, Roth R, Heuser J, Hammar M, Normark S & Hultgren SJ (2002) Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 295, 851-855.
9. Claessen D, Rink R, de Jong W, Siebring J, de Vreugd P, Boersma FG, Dijkhuizen L & Wosten HA (2003) A novel class of secreted hydrophobic proteins is involved in aerial hyphae formation in Streptomyces coelicolor by forming amyloid-like fibrils. Genes Dev 17, 1714-1726.
10. Gebbink MF, Claessen D, Bouma B, Dijkhuizen L & Wosten HA (2005) Amyloids - A functional coat for microorganisms. Nat Rev Microbiol 3, 333-341.
11. Gazit E (2002) The 'correctly-folded' state of proteins: Is it a metastable state? Angew Chem Int Ed Engl 41, 257-259.
12. Jarrett JT & Lansbury PT Jr (1993) Seeding One-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058.
13. Westermark P, Engström U, Johnson KH, Westermark GT & Betsholtz C (1990) Islet amyloid polypeptide: Pin-pointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 87, 5036-5040.
14. Westermark GT, Engström U & Westermark P (1992) The N-terminal segment of protein AA determines its fibrillogenic property. Biochem Biophys Res Commun 182, 27-33.
15. Häggqvist B, Näslund J, Sletten K, Westermark GT, Mucchiano G, Tjernberg LO, Nordstedt C, Engström U & Westermark P (1999) Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid. Proc Natl Acad Sci USA 96, 8669-8674.
16. Jaikaran ET & Clark A (2001) Islet amyloid and type 2 diabetes: From molecular misfolding to islet pathophysiology. Biochim Biophys Acta 1537, 179-203.
17. Maury CP & Nurmiaho-Lassila EL (1992) Creation of amyloid fibrils from mutant Asn187 gelsolin peptides. Biochem Biophys Res Commun 183, 227-231.
18. Reches M & Gazit E (2004) Amyloidogenic hexapeptide fragment of medin: Homology to functional islet amyloid polypeptide fragments. Amyloid 11, 81-89.
19. Tenidis K, Waldner M, Bernhagen J, Fischle W, Bergmann M, Weber M, Merkle ML, Voelter W, Brunner H & Kapurniotu A (2000) Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J Mol Biol 295, 1055-1071.
20. Balbach JJ, Ishii Y, Antzutkin ON, Leapman RD, Rizzo NW, Dyda F, Reed J & Tycko R (2000) Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR. Biochemistry 39, 13748-13759.
21. Reches M, Porat Y & Gazit E (2002) Amyloid fibril formation by pentapeptide and tetrapeptide fragments of human calcitonin. J Biol Chem 277, 35475-35480.
22. Mazor Y, Gilead S, Benhar I & Gazit E (2002) Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide. J Mol Biol 322, 1013-1024.
23. Tjernberg L, Hosia W, Bark N, Thyberg J & Johansson J (2002) Charge attraction and beta propensity are necessary for amyloid fibril formation from tetrapeptides. J Biol Chem 277, 43243-43246.
24. Reches M & Gazit E (2003) Casting metal nanowires within discrete self-assembled peptide nanotubes. Science 300, 625-627.
25. Gazit E (2002) A possible role for π-stacking in the self-assembly of amyloid fibrils. FASEB J 16, 77-83.
26. Aggeli A, Bell M, Boden N, Keen JN, Knowles PF, McLeish TC, Pitkeathly M & Radford SE (1997) Responsive gels formed by the spontaneous self-assembly of peptides into polymeric beta-sheet tapes. Nature 386, 259-262.
27. Azriel R & Gazit E (2001) Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. An experimental support for the key role of the phenylalanine residue in amyloid formation. J Biol Chem 276, 34156-34161.
28. Priola SA & Chesebro B (1998) Abnormal properties of prion protein with insertional mutations in different cell types. J Biol Chem 273, 11980-11985.
29. Li L & Lindquist S (2000) Creating a protein-based element of inheritance. Science 287, 661-664.
30. Lazo ND & Downing DT (1998) Amyloid fibrils may be assembled from beta-helical protofibrils. Biochemistry 37, 1731-1735.
31. Lazo ND & Downing DT (1999) Fibril formation by amyloid-beta proteins may involve beta-helical protofibrils. J Peptide Res 53, 633-640.
32. Jenkins J & Pickersgill R (2001) The architecture of parallel beta-helices and related folds. Prog Biophys Mol Biol 77, 111-175.
33. Huang W, Matte A, Li Y, Kim YS, Linhardt RJ, Su H & Cygler M (1999) Crystal structure of chondroitinase B from Flavobacterium heparinum and its complex with a disaccharide product at 1.7 A resolution. J Mol Biol 294, 1257-1269.
34. 13C solid-state NMR spectroscopy. Magn Resort Chem 42, 247-257.
35. Makin OS, Atkins E, Sikorski P, Johansson J & Serpell LC (2005) Molecular basis for amyloid fibril formation and stability. Proc Natl Acad Sci USA 102, 315-320.
36. Tartaglia GG, Cavalli A, Pellarin R & Caflisch A (2004) The role of aromaticity, exposed surface, and dipole moment in determining protein aggregation rates. Protein Sci 13, 1939-1941.
37. Zanuy D & Nussinov R (2003) The sequence dependence of fiber organization. A comparative molecular dynamics study of the islet amyloid polypeptide segments 22-27 and 22-29. J Mol Biol 329, 565-584.
38. Zanuy D, Porat Y, Gazit E & Nussinov R (2004) Peptide sequence and amyloid formation; molecular simulations and experimental study of a human islet amyloid polypeptide fragment and its analogues. Structure 12, 439-455.
39. Haspel N, Zanuy D, Ma B, Wolfson H & Nussinov R (2005) A comparative study of amyloid fibril formation by residues 15-19 of the human calcitonin hormone: a single beta-sheet model with a small hydrophobic core. J Mol Biol 345, 1213-1239.
40. Wu C, Lei H & Duan Y (2005) The Role of Phe in the formation of well-ordered oligomers of amyloidogenic hexapeptide (NFGAIL) observed in molecular dynamics simulations with explicit solvent. Biophys J 88, 2897-2906.
41. Colombo G, Daidone I, Gazit E, Amadei A & Di Nola A (2005) Molecular dynamics simulation of the aggregation of the core-recognition motif of the islet amyloid polypeptide in explicit water. Proteins 59, 519-527.
42. Tjernberg LO, Naslund J, Lindqvist F, Johansson J, Karlstrom AR, Thyberg J, Terenius L & Nordstedt C (1996) Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J Biol Chem 271, 8545-8548.
43. Tjernberg LO, Lilliehook C, Callaway DJ, Naslund J, Hahne S, Thyberg J, Terenius L & Nordstedt C (1997) Controlling amyloid beta-peptide fibril formation with protease-stable ligands. J Biol Chem 272, 12601-12605.
44. Soto C, Sigurdsson EM, Morelli L, Kumar RA, Castano EM & Frangione B (1998) Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med 4, 822-826.
45. Pallitto MM, Ghanta J, Heinzelman P, Kiessling LL & Murphy RM (1999) Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity. Biochemistry 38, 3570-3578.
46. Findeis MA, Musso GM, Arico-Muendel CC, Benjamin HW, Hundal AM, Lee JJ, Chin J, Kelley M, Wakefield J, Hayward NJ, et al. (1999) Modified-peptide inhibitors of amyloid beta-peptide polymerization. Biochemistry 38, 6791-6800.
47. Findeis MA (2002) Peptide inhibitors of beta amyloid aggregation. Curr Top Med Chem 2, 417-423.
48. Adessi C, Frossard MJ, Boissard C, Fraga S, Bieler S, Ruckle T, Vilbois F, Robinson SM, Mutter M, Banks WA, et al. (2003) Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease. J Biol Chem 278, 13905-13911.
49. Scrocchi LA, Ha K, Chen Y, Wu L, Wang F & Fraser PE (2003) Identification of minimal peptide sequences in the (8-20) domain of human islet amyloid polypeptide involved in fibrillogenesis. J Mol Biol 141, 218-227.
50. Gilead S & Gazit E (2004) Inhibition of amyloid fibril formation by peptide analogues modified with alpha-aminoisobutyric acid. Angew Chem Int Ed Engl 43, 4041-4044.
51. Aitken JF, Loomes KM, Konarkowska B & Cooper GJ (2003) Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid. Biochem J 374, 779-784.
52. De Felice FG, Vieira MN, Saraiva LM, Figueroa-Villar JD, Garcia-Abreu J, Liu R, Chang L, Klein WL & Ferreira ST (2004) Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization. FASEB J 18, 1366-1372.
53. Porat Y, Mazor Y, Efrat S & Gazit E (2004) Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions. Biochemistry 43, 14454-14462.
54. Ono K, Yoshiike Y, Takashima A, Hasegawa K, Naiki H & Yamada M (2003) Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J Neurochem 87, 172-181.
55. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, et al. (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280, 5892-5901.
56. Hunter CA, Lawson KR, Perkins J & Urch CJ (2001) Aromatic interactions. J Chem Soc Perkin Trans 2, 651-669.
57. Jones S, Manning J, Kad NM & Radford SE (2003) Amyloid-forming peptides from beta2-microglobulin - insights into the mechanism of fibril formation in vitro. J Mol Biol 325, 249-257.